Life in the Lab

Australia’s BANDIT (baricitinib in new onset type 1 diabetes trial trial) explained

Posted 12th August 2021

Lead scientists and clinicians from the research team explain the BANDIT (baricitinib in new onset type 1 diabetes) trial - what causes the disease and how they are hoping baricitinib may help newly-diagnosed people retain their insulin production for longer.

The trial is still open and people aged 10 - 30 who have been diagnosed with type 1 diabetes in the last 100 days are encouraged to apply. For more information, or to register, visit www.svi.edu.au/bandit Thank you to JDRF for funding this trial.

SVI’s Rising Star Program

Posted 12th August 2021

Early career researchers are the engines that drive medical research discovery. Learn more about our brilliant and ambitious young researchers whose careers are being fostered by SVI's Rising Stars Program.

SVI Rising Star Dr Astrid Glaser

Posted 09th January 2020

SVI 'Rising Star' Astrid Glaser, a postdoctoral researcher from our Genome Stability Unit, talks about her work in CRISPR Cas-9 technology and Fanconi Anaemia, and the importance of philanthropic support.

SVI Rising Star Dr Jacki Heraud-Farlow

Posted 09th January 2020

SVI postdoctoral researcher Jacki Heraud-Farlow, a postdoctoral researcher from our RNA & Cancer Laboratory, talks about her work on a gene called ADAR1, and the importance of philanthropic support. Jacki is the recipient of SVI's 2019 Rising Star Award and the 5point Foundation's Christine Martin Fellowship.

SVI Rising Star Dr Jess Holien

Posted 09th January 2020

SVI 'Rising Star' and postdoctoral researcher Dr Jess Holien, Team Leader Structural Bioinformatics and Drug Discovery, talks about her ovarian cancer research project, and the importance of philanthropic support.

Women in Research 2019

Posted 08th August 2019

Dr Jess Holien's daughter explains "what her mother does all day'", in this video created for the Susan Alberti Medical Research Foundation's Annual Mother's Day Luncheon (2019).